197 related articles for article (PubMed ID: 32339553)
1. Lipid-based biomarkers for CVD, COPD, and aging - A translational perspective.
Ekroos K; Lavrynenko O; Titz B; Pater C; Hoeng J; Ivanov NV
Prog Lipid Res; 2020 Apr; 78():101030. PubMed ID: 32339553
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Biomarkers in the Identification of Future Risk in Chronic Obstructive Pulmonary Disease.
Jahn K; Papakonstantinou E; Stolz D
Curr Top Med Chem; 2016; 16(14):1539-49. PubMed ID: 26420369
[TBL] [Abstract][Full Text] [Related]
3. Lipidomics applications for discovering biomarkers of diseases in clinical chemistry.
Zhao YY; Cheng XL; Lin RC
Int Rev Cell Mol Biol; 2014; 313():1-26. PubMed ID: 25376488
[TBL] [Abstract][Full Text] [Related]
4. Lipidomic insight into cardiovascular diseases.
Kohno S; Keenan AL; Ntambi JM; Miyazaki M
Biochem Biophys Res Commun; 2018 Oct; 504(3):590-595. PubMed ID: 29665359
[TBL] [Abstract][Full Text] [Related]
5. Biomarker Development in COPD: Moving From P Values to Products to Impact Patient Care.
Hollander Z; DeMarco ML; Sadatsafavi M; McManus BM; Ng RT; Sin DD
Chest; 2017 Feb; 151(2):455-467. PubMed ID: 27693595
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Markers of Inflammation and Oxidative Stress in COPD Patients with or without Cardiovascular Comorbidities.
Kaźmierczak M; Ciebiada M; Pękala-Wojciechowska A; Pawłowski M; Nielepkowicz-Goździńska A; Antczak A
Heart Lung Circ; 2015 Aug; 24(8):817-23. PubMed ID: 25797323
[TBL] [Abstract][Full Text] [Related]
7. Blood-Derived Lipid and Metabolite Biomarkers in Cardiovascular Research from Clinical Studies: A Recent Update.
Kale D; Fatangare A; Phapale P; Sickmann A
Cells; 2023 Dec; 12(24):. PubMed ID: 38132115
[TBL] [Abstract][Full Text] [Related]
8. Systematic review on recent potential biomarkers of chronic obstructive pulmonary disease.
Aydindogan E; Penque D; Zoidakis J
Expert Rev Mol Diagn; 2019 Jan; 19(1):37-45. PubMed ID: 30560707
[No Abstract] [Full Text] [Related]
9. Blood and sputum protein biomarkers for chronic obstructive pulmonary disease (COPD).
Moon JY; Leitao Filho FS; Shahangian K; Takiguchi H; Sin DD
Expert Rev Proteomics; 2018 Nov; 15(11):923-935. PubMed ID: 30362838
[TBL] [Abstract][Full Text] [Related]
10. [Cardiac troponins - biomarkers for cardiovascular disease in chronic obstructive pulmonary disease].
Michelini Truedsson M; Stagmo M; Alm Hirsch I; Malm J; Marko-Varga G; Piitulainen E
Lakartidningen; 2020 Feb; 117():. PubMed ID: 32096867
[TBL] [Abstract][Full Text] [Related]
11. Chronic Diseases and Lifestyle Biomarkers Identification by Metabolomics.
Mastrangelo A; Barbas C
Adv Exp Med Biol; 2017; 965():235-263. PubMed ID: 28132183
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers in COPD.
Tzortzaki EG; Lambiri I; Vlachaki E; Siafakas NM
Curr Med Chem; 2007; 14(9):1037-48. PubMed ID: 17439401
[TBL] [Abstract][Full Text] [Related]
13. New and emerging biomarkers in cardiovascular disease.
Cahill LE; Bertoia ML; Aroner SA; Mukamal KJ; Jensen MK
Curr Diab Rep; 2015 Nov; 15(11):88. PubMed ID: 26370699
[TBL] [Abstract][Full Text] [Related]
14. Statin Effects on Exacerbation Rates, Mortality, and Inflammatory Markers in Patients with Chronic Obstructive Pulmonary Disease: A Review of Prospective Studies.
Howard ML; Vincent AH
Pharmacotherapy; 2016 May; 36(5):536-47. PubMed ID: 26990316
[TBL] [Abstract][Full Text] [Related]
15. Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia.
Arshad H; Alfonso JCL; Franke R; Michaelis K; Araujo L; Habib A; Zboromyrska Y; Lücke E; Strungaru E; Akmatov MK; Hatzikirou H; Meyer-Hermann M; Petersmann A; Nauck M; Brönstrup M; Bilitewski U; Abel L; Sievers J; Vila J; Illig T; Schreiber J; Pessler F
J Transl Med; 2019 Nov; 17(1):365. PubMed ID: 31711507
[TBL] [Abstract][Full Text] [Related]
16. From proteomics to prescription-the search for COPD biomarkers.
Nicholas BL; O'Connor CD; Djukanovic R
COPD; 2009 Aug; 6(4):298-303. PubMed ID: 19811390
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota: A New Marker of Cardiovascular Disease.
Garcia-Rios A; Torres-Peña JD; Perez-Jimenez F; Perez-Martinez P
Curr Pharm Des; 2017; 23(22):3233-3238. PubMed ID: 28317481
[TBL] [Abstract][Full Text] [Related]
18. [Oxidative DNA damage in the pathogenesis of chronic obstructive pulmonary disease in older patients].
Kytikova OY; Gvozdenko TA; Vitkina TI
Adv Gerontol; 2016; 29(5):784-787. PubMed ID: 28556650
[TBL] [Abstract][Full Text] [Related]
19. Conventional and innovative methods to assess oxidative stress biomarkers in the clinical cardiovascular setting.
Gaggini M; Sabatino L; Vassalle C
Biotechniques; 2020 Apr; 68(4):223-231. PubMed ID: 32066251
[TBL] [Abstract][Full Text] [Related]
20. [What is the place for biomarkers during acute COPD exacerbations?].
Claessens YE; Weiss N; Riqué T; Mallet-Coste T
Rev Mal Respir; 2017 Apr; 34(4):382-394. PubMed ID: 28499640
[No Abstract] [Full Text] [Related]
[Next] [New Search]
